Search research articles
Contact Us
Filters
Showing results (1-10 of 91) with videos related to
Page
of 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2015
Is There Any True Association Between BRAF V600E Mutation and Recurrence, Particularly in Low-Risk, Papillary Thyroid Cancer?
Chandrasekhar Bal, Sanjana Ballal
The Indian Journal of Medical Research
|
July 28, 2017
Re-establishment of normal radioactive iodine uptake reference range in the era of universal salt iodization in the Indian population
Sanjana Ballal, Ramya Soundararajan, Chandrasekhar Bal
Indian Journal of Endocrinology and Metabolism
|
May 26, 2012
Stunning in post (131)I therapy scans after low-dose (131)I diagnostic whole body scans with differentiated thyroid cancer in the Indian patient population: Critical importance of interval between the two scans
Nishikant A Damle, Chandrasekhar Bal, Sanjana Ballal
EJNMMI Research
|
February 7, 2019
Concomitant <sup>177</sup>Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
Madhav Prasad Yadav, Sanjana Ballal, Chandrasekhar Bal
Clinical Nuclear Medicine
|
May 18, 2016
Cocktail Therapy of 177Lu-PSMA-617 and 177Lu-EDTMP in Patients With mCRPC: A Proof-of-Principle Application
Chandrasekhar Bal, Madhav Prasad Yadav, Sanjana Ballal
AJR. American Journal of Roentgenology
|
June 23, 2020
Reply to "Fact-Checking on <sup>177</sup>Lu-PSMA Nephrotoxicity"
Sanjana Ballal, Madhav Prasad Yadav, Chandrasekhar Bal
The Journal of Clinical Endocrinology and Metabolism
|
January 12, 2024
Optimal Cumulative I-131 Activity in Metastatic Differentiated Thyroid Cancer: Balancing Efficacy and Adverse Events
Mangu Srinivas Bharadwaj, Sanjana Ballal, Chandrasekhar Bal
Thyroid : Official Journal of the American Thyroid Association
|
August 19, 2022
Propensity Score Matched Outcome Analysis of Lobar Ablation Versus Completion Thyroidectomy in Low-Risk Differentiated Thyroid Cancer Patients: Median Follow-Up of 11 Years
Chandrasekhar Bal, Swayamjeet Satapathy, Avinash Tupalli, et al.
Clinical Nuclear Medicine
|
November 17, 2023
Complete Response to 177 Lu-DOTATATE PRRT in a 9-Year-Old Child With Metastatic Carotid Body Paraganglioma
Madhav Prasad Yadav, Shobhana Raju, Sanjana Ballal, et al.
Clinical Endocrinology
|
July 22, 2014
Lung metastases from differentiated thyroid carcinoma: prognostic factors related to remission and disease-free survival
Saurav Chopra, Aayushi Garg, Sanjana Ballal, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 91) with videos related to
Sort By:
Page
of 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2015
Is There Any True Association Between BRAF V600E Mutation and Recurrence, Particularly in Low-Risk, Papillary Thyroid Cancer?
Chandrasekhar Bal, Sanjana Ballal
The Indian Journal of Medical Research
|
July 28, 2017
Re-establishment of normal radioactive iodine uptake reference range in the era of universal salt iodization in the Indian population
Sanjana Ballal, Ramya Soundararajan, Chandrasekhar Bal
Indian Journal of Endocrinology and Metabolism
|
May 26, 2012
Stunning in post (131)I therapy scans after low-dose (131)I diagnostic whole body scans with differentiated thyroid cancer in the Indian patient population: Critical importance of interval between the two scans
Nishikant A Damle, Chandrasekhar Bal, Sanjana Ballal
EJNMMI Research
|
February 7, 2019
Concomitant <sup>177</sup>Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
Madhav Prasad Yadav, Sanjana Ballal, Chandrasekhar Bal
Clinical Nuclear Medicine
|
May 18, 2016
Cocktail Therapy of 177Lu-PSMA-617 and 177Lu-EDTMP in Patients With mCRPC: A Proof-of-Principle Application
Chandrasekhar Bal, Madhav Prasad Yadav, Sanjana Ballal
AJR. American Journal of Roentgenology
|
June 23, 2020
Reply to "Fact-Checking on <sup>177</sup>Lu-PSMA Nephrotoxicity"
Sanjana Ballal, Madhav Prasad Yadav, Chandrasekhar Bal
The Journal of Clinical Endocrinology and Metabolism
|
January 12, 2024
Optimal Cumulative I-131 Activity in Metastatic Differentiated Thyroid Cancer: Balancing Efficacy and Adverse Events
Mangu Srinivas Bharadwaj, Sanjana Ballal, Chandrasekhar Bal
Thyroid : Official Journal of the American Thyroid Association
|
August 19, 2022
Propensity Score Matched Outcome Analysis of Lobar Ablation Versus Completion Thyroidectomy in Low-Risk Differentiated Thyroid Cancer Patients: Median Follow-Up of 11 Years
Chandrasekhar Bal, Swayamjeet Satapathy, Avinash Tupalli, et al.
Clinical Nuclear Medicine
|
November 17, 2023
Complete Response to 177 Lu-DOTATATE PRRT in a 9-Year-Old Child With Metastatic Carotid Body Paraganglioma
Madhav Prasad Yadav, Shobhana Raju, Sanjana Ballal, et al.
Clinical Endocrinology
|
July 22, 2014
Lung metastases from differentiated thyroid carcinoma: prognostic factors related to remission and disease-free survival
Saurav Chopra, Aayushi Garg, Sanjana Ballal, et al.
Page
of 10